Novo Nordisk (NOVOB DC) to present new data on Wegovy, women with obesity and next-generation weight loss treatments at European Congress on Obesity

Novo Nordisk's presentation of new data on Wegovy at the European Congress on Obesity highlights promising developments in obesity treatment that could significantly impact both their market position and the industry at large.

Newsquawk StaffPublished 28 Apr 2026, 12:22 UTCOn the live feed at 12:02 UTC — 7 more headlines followed before this page went public

Newsquawk headlinesUTC

12:11

Spotify (SPOT) expresses confidence in sustained user and subscriber growth, citing low churn and anticipating continued progress on revenue and margin throughout the year, following a strong start driven by solid execution and healthy engagement

12:06

Sysco (SYY) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.95), Revenue 20.5bln (exp. 20.55bln); delivering FY adj. EPS at high end of 4.50-4.60 range

12:02

Novo Nordisk (NOVOB DC) to present new data on Wegovy, women with obesity and next-generation weight loss treatments at European Congress on Obesity

12:01

PACCAR Inc (PCAR) Q1 2026 (USD): EPS 1.15 (exp. 1.15), Revenue 6.78bln (exp. 6.51bln)

12:01

Ecolab Inc. (ECL) Q1 2026 (USD): Adj. EPS 1.70 (exp. 1.70), Revenue 4.07bln (exp. 4.03bln)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Analyses of the higher dose of Wegovy® (semaglutide 7.2 mg) and Wegovy® pill (oral semaglutide 25 mg) show how fast and how much sustained weight loss people who responded early to treatment achieved
Wegovy® (semaglutide 2.4 mg and 7.2 mg) clinical and real-world data exploring its role in managing menopausal symptoms, including weight gain and migraine, and lowering cardiovascular risk
Data on next-generation obesity pipeline, including the advanced combined amylin and GLP-1 receptor analogues

Context

The focus on sustained weight loss and its role in menopause management suggests potential for expanded usage and new market opportunities, which might attract investor interest and influence stock performance.

All markets · last 90 days

Recent headlines that moved markets

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

Modest downside seen across equity futures as energy prices tick higher.

ENERGY/8 Sept · 05:23 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Brent Nov'26, after we published+1.0%

ENERGY/3 Sept · 08:03 UTC

Russian President Putin says that Russia and Ukraine should agree first; he notes that there is an opportunity to reach a peace agreement.

with Brent Nov, after we published−1.3%

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

ENERGY/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

- Brent (V6), after we published+1.2%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.